echemi logo
Product
  • Product
  • Supplier
  • Inquiry

    DGK Assay

    • Last Update: 2021-02-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Buffers:- 2X buffer
    10 ml 0.5 M imidazol, pH 6.6
    0.21 g LiCl
    1.25 ml 1 M MgCl2
    1.0 ml 0.1 M EGTA, pH 6.6
    --> Bring volume up to 50 ml with distilled water.- dilution buffer
    1 ml 0.5 M imidazol, pH 6.6
    2.5 ml 20 mM diethylenetriaminepentaacetic acid (DTPA)
    --> Bring volume up to 50 ml with distilled water.Reaction Mixture:solution [stock] vol/tube # samples total vol.2X buffer - 50 µl X _______ = _______DTT
    1 M 0.2 µl X _______ = _______DGK membrane 3.8 µg/µl 0.44 µl X _______ = _______ dilution buffer - 19.36 µl X _______ = _______ total = _______ 1) Treat and harvest cells. 2) Extract lipids via a basic Bligh-Dyer extraction:
    a) Resuspend cell pellet in 3 ml chloroform/methanol (1:2) & vortex.
    b) Add 0.8 ml water & vortex.
    c) Pellet cellular debris by spinning at 3,000 rpm (2000xg) for 5 min.
    d) Add 1 ml chloroform & vortex.
    e) Add 1 ml water & vortex.
    f) Discard upper, aqueous phase. 3) Collect 1.2-1.5 ml of the lower phase (total volume of lower phase should constitute 2 ml, but to prevent any aqueous contamination only a portion is used).
    ---> Also aliquot standards: 10, 20, 40, 80 & 160 pmoles of ceramide and diolein. 4) Dry down lipids using extra dry nitrogen gas. 5) Resuspend lipids in each tube in 20 µl of b-OG/DOPG (7.5%:25 mM mixed micelle) and vortex vigorously.
    ---> Have a blank tube containing b-OG/DOPG only. 6) Sonicate samples briefly and again vortex vigorously.
    ---> This step is only necessary if the lipid is not readily "going into solution." 7) Add 70 µl of reaction mixture to each sample and vortex vigorously. 8) Add 10 µl of 2 mM, 4 µCi [g-32P] ATP to each tube to initiate reaction.
    ---> When preparing the mixture of hot and cold ATP assume that the hot ATP constitutes insignificant concentrations of ATP. 9) Allow reaction to proceed for 30 minutes at room temperature. 10) Stop reaction with 3 ml of chloroform/methanol (1:2) & vortex. 11) Add 0.7 ml water to each sample & vortex.
    ---> Some protocols use 1% HClO4 instead of water at this step and at step 13. 12) Add 1 ml of chloroform to each sample & vortex. 13) Add 1 ml water to each sample & vortex. 14) Spin samples @ 3,000 rpm (2000xg) for 5 minutes. 15) Aspirate off the upper phase and collect 1.2-1.5 ml of lower phase. NOTE:
    The upper phase contains most of the radioactivity, so be very careful when aspirating! 16) Dry down samples, resuspend in chloroform and spot on TLC plates (Whatman Silica Gel 60A plates, catalog #: 4866-821). 17) Develop plates in TLC chamber containing the following solvent system:
    ---> chloroform/acetone/methanol/acetic acid/water
    (10:4:3:2:1) 18) Expose film overnight. 19) Develop film, scrape spots & count ceramide phosphate, phosphatidic acid and lyso-phosphatidic acid spots.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.